Thousands of people around the world have started microdosing psychedelics, like LSD and psilocybin, for their health benefits. Clinical scientist Joseph Rootman collaborated with an international team of researchers to roll out the largest study of psychedelic microdosing to date. He will walk listeners through the findings of this study and introduce them to the who, what, and why of this new and exciting practice. Joseph Rootman is a doctoral candidate in the clinical psychology program at the University of British Columbia. He works under the supervision of Dr. Zach Walsh in the Therapeutic, Recreational and Problematic Substance Use Lab, with a specialization in research into the therapeutic potential of cannabis and psychedelics such as psilocybin, LSD and ketamine. Joseph is the lead author of two recent publications in Nature: Scientific Reports that highlight the potential therapeutic benefits of psychedelic microdosing on mood,
mental health and cognition. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
Please take the opportunity to connect and share this video with your friends and family if you find it useful.
